Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis.

Trial Profile

Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Neuronal ceroid lipofuscinosis
  • Focus Adverse reactions
  • Acronyms JUMP
  • Sponsors University of Rochester
  • Most Recent Events

    • 04 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record
    • 18 Mar 2013 Planned end date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top